News

Life Sciences News & Trends

Why you shouldn’t say “this study is underpowered”Ensuring our critiques of power are relevant, clear, and based on good statistics

November 1, 2023

Tools like ChatGPT can personalize clinical trials tech — if companies avoid the pitfalls

September 23, 2023

Adlai, building on the ashes of Novartis' failure, raises $57.5M IPO to run phase 3 cancer trial

Page updated

Report abuse